- Profile / Contact Info
- E-Mail Company
- News & Press Releases
 | Products / Services: |  |
| Baxter Healthcare Corp is currently listed under the following categories: | ||
|
 |  |
| RSS / XML Feeds: | |
 | ||
 | ||
 | ||
 |
| |
| Baxter Healthcare Corp | Deerfield, IL | |
| |||||||||
| * Click on an image to enlarge it in a new window * | |||||||||
 | Baxter Builds on Global Leadership in Hemophilia A Treatment 29 May 2014 New Approvals and Tenders Support Increased Access to ADVATE, The World's Market Leading Recombinant FVIII Treatment  | ||||||||
| Baxter to Present at the Goldman Sachs 35th Annual Global Healthcare Conference 29 May 2014 Webcast of Baxter's presentation can be accessed from the Baxter corporate website at www.baxter.com and will be available for replay through July 9, 2014 | ||||||||
 | Baxter Receives 510(k) Clearance for Next-Generation SIGMA Spectrum Infusion Pump with Master Drug Library 8 May 2014 Improvements Include Increased Drug Library Capacity and Device Tracking Services | ||||||||
| Baxter Raises Quarterly Dividend Six Percent 8 May 2014 Increase results in an annual dividend rate of $2.08 per diluted share. Baxter has more than doubled the dividend since 2008, and the new rate maintains a dividend payout ratio of approximately 40 percent. | ||||||||
| Baxter to Present at the Bank of America Merrill Lynch 2014 Health Care Conference 30 Apr 2014 Llive webcast of presentation can be accessed from the Baxter corporate website at www.baxter.com and will be available for replay through June 13th | ||||||||
| Baxter to Present at the Deutsche Bank 39th Annual Health Care Conference 25 Apr 2014 Live webcast of Baxter's presentation can be accessed from the Baxter corporate website at Baxter.com and will be available for replay through June 6 | ||||||||
| Baxter Announces FDA Approval of ADVATE (Antihemophilic Factor [Recombinant]) with BAXJECT III Reconstitution System 23 Apr 2014 New reconstitution system was developed to reduce the number of steps in the reconstitution process for hemophilia A patients and caregivers | ||||||||
| Baxter to Webcast Annual Meeting of Shareholders 22 Apr 2014 Meeting will be webcast by Nasdaq OMX and can be accessed along with accompanying slides from Baxter's Web site at www.baxter.com. | ||||||||
| On World Hemophilia Day, Baxter Envisions Future of Hemophilia Care 17 Apr 2014 Position Paper Cites Opportunities to Improve Care for Hemophilia Patients Worldwide | ||||||||
| Baxter Reports Strong First Quarter Financial Results Exceeding Expectations & Confirms 2014 Full-Year Guidance 17 Apr 2014 Momentum Continues On Advancing New Product Pipeline And Positioning Company for Future Growth | ||||||||
| Baxter Meets Primary Efficacy Endpoint in Phase 3 Trial of BAX 111 16 Apr 2014 Investigational stand-alone recombinant treatment for von Willebrand Disease, the most common type of inherited bleeding disorder. | ||||||||
| |
| Showing 1-11 of 53 News Releases |  | |
| 1 2 3 4 5 (5 pages total) |
